Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure
- 31 August 2012
- journal article
- research article
- Published by Elsevier BV in Surgery
- Vol. 152 (3), S43-S49
- https://doi.org/10.1016/j.surg.2012.05.020
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Contribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer ProgressionJournal of Surgical Research, 2012
- Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant TherapyJournal of the American College of Surgeons, 2012
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III TrialAnnals of Surgical Oncology, 2011
- Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After PancreaticoduodenectomyAnnals of Surgery, 2010
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic AdenocarcinomaJNCI Journal of the National Cancer Institute, 2010
- Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic CancerAnnals of Surgical Oncology, 2008
- 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution ExperienceJournal of Gastrointestinal Surgery, 2006
- Analysis of Long-term Survivors After Surgical Resection for Pancreatic CancerPancreas, 2006
- Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivorsJournal of the American College of Surgeons, 2004
- Pancreatic CarcinomaThe New England Journal of Medicine, 1992